A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergies

Abstract Should oral isotretinoin be considered contraindicated in patients with peanut, soybean, and cashew allergies? A systematic literature search of PubMed, EMBASE and The Cochrane Library up to July 2023 was conducted to identify randomised control trials (RCTs), cohort studies, case reports,...

Full description

Saved in:
Bibliographic Details
Main Authors: Naayema Hussaini, Nabihah Hussaini, Jousef Bakir, Rabeea Mirza, Rubina Fatima
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:JEADV Clinical Practice
Subjects:
Online Access:https://doi.org/10.1002/jvc2.536
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849393505714044928
author Naayema Hussaini
Nabihah Hussaini
Jousef Bakir
Rabeea Mirza
Rubina Fatima
author_facet Naayema Hussaini
Nabihah Hussaini
Jousef Bakir
Rabeea Mirza
Rubina Fatima
author_sort Naayema Hussaini
collection DOAJ
description Abstract Should oral isotretinoin be considered contraindicated in patients with peanut, soybean, and cashew allergies? A systematic literature search of PubMed, EMBASE and The Cochrane Library up to July 2023 was conducted to identify randomised control trials (RCTs), cohort studies, case reports, and cross‐sectional studies investigating if isotretinoin should be contraindicated in patients with various allergies including peanut, soybean, and cashew allergies. Primary outcomes explored included relapse, adverse effects, and safety profiles of oral isotretinoin at varying doses. Secondary outcomes included efficacy as well as economic considerations. The quality of studies, including risk of bias, was assessed using GRADE (Grading of Recommendations, Assessment, Development and Evaluations). A total of eight studies were included. The majority of studies suggested that isotretinoin should not be considered inadvisable. In cases with peanut allergies, minimal adverse effects were noted with various dosages of isotretinoin and prolonged treatment duration. In cases with soybean allergies, similar results and conclusions were obtained to the cases with peanut allergies, however the number of studies were not of similar value to those of peanut allergies. Comparison between studies was challenging due to differing methods of assessment, subjective interpretation of severity and duration of follow‐up. This review highlights the need for an adequately powered RCT, to decipher whether isotretinoin should not be given to patients with peanut, soybean or cashew allergies.
format Article
id doaj-art-244068a7532249e7b2d64c6372b6eeef
institution Kabale University
issn 2768-6566
language English
publishDate 2025-03-01
publisher Wiley
record_format Article
series JEADV Clinical Practice
spelling doaj-art-244068a7532249e7b2d64c6372b6eeef2025-08-20T03:40:24ZengWileyJEADV Clinical Practice2768-65662025-03-0141424810.1002/jvc2.536A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergiesNaayema Hussaini0Nabihah Hussaini1Jousef Bakir2Rabeea Mirza3Rubina Fatima4Lewisham and Greenwich NHS Trust London UKUniversity of Manchester Manchester UKUniversity of Manchester Manchester UKDeccan College of Medical Sciences Hyderabad IndiaNHS Scotland Glasgow UKAbstract Should oral isotretinoin be considered contraindicated in patients with peanut, soybean, and cashew allergies? A systematic literature search of PubMed, EMBASE and The Cochrane Library up to July 2023 was conducted to identify randomised control trials (RCTs), cohort studies, case reports, and cross‐sectional studies investigating if isotretinoin should be contraindicated in patients with various allergies including peanut, soybean, and cashew allergies. Primary outcomes explored included relapse, adverse effects, and safety profiles of oral isotretinoin at varying doses. Secondary outcomes included efficacy as well as economic considerations. The quality of studies, including risk of bias, was assessed using GRADE (Grading of Recommendations, Assessment, Development and Evaluations). A total of eight studies were included. The majority of studies suggested that isotretinoin should not be considered inadvisable. In cases with peanut allergies, minimal adverse effects were noted with various dosages of isotretinoin and prolonged treatment duration. In cases with soybean allergies, similar results and conclusions were obtained to the cases with peanut allergies, however the number of studies were not of similar value to those of peanut allergies. Comparison between studies was challenging due to differing methods of assessment, subjective interpretation of severity and duration of follow‐up. This review highlights the need for an adequately powered RCT, to decipher whether isotretinoin should not be given to patients with peanut, soybean or cashew allergies.https://doi.org/10.1002/jvc2.536accutaneacneallergydrug reactionisotretinoin
spellingShingle Naayema Hussaini
Nabihah Hussaini
Jousef Bakir
Rabeea Mirza
Rubina Fatima
A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergies
JEADV Clinical Practice
accutane
acne
allergy
drug reaction
isotretinoin
title A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergies
title_full A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergies
title_fullStr A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergies
title_full_unstemmed A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergies
title_short A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergies
title_sort systematic review of isotretinoin and its contraindications in peanut soybean and cashew nut allergies
topic accutane
acne
allergy
drug reaction
isotretinoin
url https://doi.org/10.1002/jvc2.536
work_keys_str_mv AT naayemahussaini asystematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies
AT nabihahhussaini asystematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies
AT jousefbakir asystematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies
AT rabeeamirza asystematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies
AT rubinafatima asystematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies
AT naayemahussaini systematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies
AT nabihahhussaini systematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies
AT jousefbakir systematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies
AT rabeeamirza systematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies
AT rubinafatima systematicreviewofisotretinoinanditscontraindicationsinpeanutsoybeanandcashewnutallergies